Compra de Fármacos Anticonvulsivantes para el Hospital de Talca
El objetivo de la presente licitacion es contar con el abastecimiento de farmacos anticonvulsivantes en cantidad, calidad y oportunidad para el periodo de 24 meses a contar de la fecha de adjudicacion en el portal mercado publico.
9 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 5051-1085-SE14 | 29-04-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $1.106.700 |
| 5051-1083-SE14 | 29-04-2014 | Laboratorios Recalcine S.A. | $182.070 |
| 5051-1084-SE14 | 29-04-2014 | Laboratorios Recalcine S.A. | $2.918.118 |
| 5051-1086-SE14 | 29-04-2014 | Novartis Chile S.A. | $583.213 |
| 5051-817-SE14 | 24-03-2014 | Laboratorios Recalcine S.A. | $107.100 |
| 5051-661-SE14 | 13-03-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $1.859.256 |
| 5051-629-SE14 | 11-03-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $176.020 |
| 5051-478-SE14 | 10-02-2014 | Laboratorios Recalcine S.A. | $203.490 |
| 5051-477-SE14 | 10-02-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $2.169.132 |
| 5051-476-SE14 | 10-02-2014 | Laboratorios Recalcine S.A. | $3.636.759 |
| 5051-449-SE14 | 06-02-2014 | Laboratorio Chile S.A. | $8.928.570 |
| 5051-273-SE14 | 21-01-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $88.536 |
| 5051-272-SE14 | 21-01-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $150.874 |
| 5051-189-SE14 | 13-01-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $75.437 |
| 5051-62-SE14 | 06-01-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $1.859.256 |
| 5051-59-SE14 | 06-01-2014 | Laboratorios Recalcine S.A. | $3.636.759 |
| 5051-60-SE14 | 06-01-2014 | Laboratorios Recalcine S.A. | $107.100 |
| 5051-61-SE14 | 06-01-2014 | Novartis Chile S.A. | $5.832.131 |
| 5051-31-SE14 | 03-01-2014 | Laboratorio Chile S.A. | $3.571.785 |
| 5051-3647-SE13 | 16-12-2013 | Laboratorios Recalcine S.A. | $65.331 |
| 5051-3642-SE13 | 16-12-2013 | Laboratorios Recalcine S.A. | $65.331 |
| 5051-3646-SE13 | 16-12-2013 | Laboratorios Recalcine S.A. | $65.331 |
| 5051-3558-SE13 | 10-12-2013 | Laboratorios Recalcine S.A. | $65.331 |
| 5051-3559-SE13 | 10-12-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $50.291 |
| 5051-3560-SE13 | 10-12-2013 | Laboratorios Recalcine S.A. | $65.331 |
| 5051-3440-SE13 | 26-11-2013 | Laboratorio Chile S.A. | $2.677.500 |
| 5051-3441-SE13 | 26-11-2013 | Laboratorios Recalcine S.A. | $3.636.759 |
| 5051-3442-SE13 | 26-11-2013 | Laboratorios Recalcine S.A. | $107.100 |
| 5051-3326-SE13 | 20-11-2013 | Laboratorios Recalcine S.A. | $587.979 |
| 5051-3157-SE13 | 03-11-2013 | Megalabs Chile S.A. | $75.398 |
| 5051-3079-SE13 | 25-10-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $1.106.700 |
| 5051-3080-SE13 | 25-10-2013 | Laboratorios Recalcine S.A. | $2.918.118 |
| 5051-3078-SE13 | 25-10-2013 | Laboratorio Chile S.A. | $1.785.893 |
| 5051-3077-SE13 | 25-10-2013 | Laboratorios Recalcine S.A. | $91.035 |
| 5051-2872-SE13 | 09-10-2013 | Laboratorios Recalcine S.A. | $137.921 |
| 5051-2871-SE13 | 09-10-2013 | Laboratorio Chile S.A. | $128.520 |
| 5051-2778-SE13 | 26-09-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $1.106.700 |
| 5051-2779-SE13 | 26-09-2013 | Laboratorios Recalcine S.A. | $2.177.700 |
| 5051-2777-SE13 | 26-09-2013 | Laboratorios Recalcine S.A. | $91.035 |
| 5051-2620-SE13 | 16-09-2013 | Laboratorios Recalcine S.A. | $65.331 |
| 5051-2614-SE13 | 12-09-2013 | Laboratorio Chile S.A. | $1.338.750 |
| 5051-2556-SE13 | 09-09-2013 | Laboratorios Recalcine S.A. | $304.878 |
| 5051-2557-SE13 | 09-09-2013 | Laboratorios Recalcine S.A. | $370.209 |
| 5051-2558-SE13 | 09-09-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $110.670 |
| 5051-2547-SE13 | 09-09-2013 | Laboratorios Recalcine S.A. | $217.770 |
| 5051-2438-SE13 | 21-08-2013 | Laboratorios Recalcine S.A. | $1.742.160 |
| 5051-2439-SE13 | 21-08-2013 | Novartis Chile S.A. | $1.722.168 |
| 5051-2437-SE13 | 21-08-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $1.106.700 |
| 5051-2325-SE13 | 16-08-2013 | Laboratorio Chile S.A. | $53.550 |
| 5051-2241-SE13 | 07-08-2013 | Laboratorios Recalcine S.A. | $91.035 |
| 5051-2169-SE13 | 05-08-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $771.133 |
| 5051-2170-SE13 | 05-08-2013 | Laboratorios Recalcine S.A. | $370.209 |
| 5051-2145-SE13 | 01-08-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $2.791.459 |
| 5051-2144-SE13 | 01-08-2013 | Laboratorio Chile S.A. | $2.142.000 |
| 5051-2044-SE13 | 26-07-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $88.536 |
| 5051-2041-SE13 | 24-07-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $116.693 |
| 5051-2042-SE13 | 24-07-2013 | Megalabs Chile S.A. | $653.453 |
| 5051-2043-SE13 | 24-07-2013 | Laboratorios Recalcine S.A. | $805.749 |
| 5051-1982-SE13 | 11-07-2013 | Laboratorios Recalcine S.A. | $144.585 |
| 5051-1708-SE13 | 11-07-2013 | Laboratorios Recalcine S.A. | $326.655 |
| 5051-1938-SE13 | 11-07-2013 | Laboratorios Recalcine S.A. | $261.324 |
| 5051-1981-SE13 | 11-07-2013 | Laboratorio Chile S.A. | $2.677.500 |
| 5051-1909-SE13 | 04-07-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $2.009.839 |
| 5051-1823-SE13 | 03-07-2013 | Novartis Chile S.A. | $1.722.168 |
| 5051-1701-SE13 | 18-06-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $110.670 |
| 5051-1693-SE13 | 17-06-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $50.291 |
| 5051-1692-SE13 | 17-06-2013 | Laboratorio Chile S.A. | $34.808 |
| 5051-1672-SE13 | 13-06-2013 | Megalabs Chile S.A. | $100.531 |
| 5051-1584-SE13 | 06-06-2013 | Novartis Chile S.A. | $3.126.022 |
| 5051-1586-SE13 | 06-06-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $1.164.828 |
| 5051-1588-SE13 | 06-06-2013 | Laboratorios Recalcine S.A. | $91.035 |
| 5051-1585-SE13 | 06-06-2013 | Laboratorio Chile S.A. | $2.677.500 |
| 5051-1499-SE13 | 31-05-2013 | Novartis Chile S.A. | $102.816 |
| 5051-1402-SE13 | 16-05-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $1.056.117 |
| 5051-1390-SE13 | 09-05-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $724.253 |
| 5051-1362-SE13 | 06-05-2013 | Laboratorios Recalcine S.A. | $64.260 |
| 5051-1217-SE13 | 25-04-2013 | Novartis Chile S.A. | $3.126.022 |
| 5051-1156-SE13 | 19-04-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $2.263.109 |
| 5051-1152-SE13 | 19-04-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $226.311 |
| 5051-1144-SE13 | 18-04-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $66.402 |
| 5051-1041-SE13 | 09-04-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $724.253 |
| 5051-983-SE13 | 05-04-2013 | Novartis Chile S.A. | $3.126.022 |
| 5051-865-SE13 | 21-03-2013 | Novartis Chile S.A. | $2.916.065 |
| 5051-867-SE13 | 21-03-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $724.253 |
| 5051-868-SE13 | 21-03-2013 | Laboratorios Recalcine S.A. | $53.550 |
| 5051-866-SE13 | 21-03-2013 | Laboratorio Chile S.A. | $1.713.600 |
| 5051-773-SE13 | 15-03-2013 | Megalabs Chile S.A. | $301.594 |
| 5051-750-SE13 | 01-03-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $301.748 |
| 5051-556-SE13 | 19-02-2013 | Laboratorios Recalcine S.A. | $53.550 |
| 5051-554-SE13 | 19-02-2013 | Laboratorio Chile S.A. | $1.338.750 |
| 5051-555-SE13 | 19-02-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $362.127 |
| 5051-482-SE13 | 12-02-2013 | Laboratorio Chile S.A. | $2.677.500 |
| 5051-311-SE13 | 30-01-2013 | Laboratorios Recalcine S.A. | $53.550 |
| 5051-308-SE13 | 30-01-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $724.253 |
| 5051-210-SE13 | 24-01-2013 | Laboratorio Chile S.A. | $1.783.215 |
| 5051-37-SE13 | 07-01-2013 | Megalabs Chile S.A. | $301.594 |
| 5051-5622-SE12 | 02-01-2013 | Laboratorios Recalcine S.A. | $74.970 |
| 5051-5619-SE12 | 02-01-2013 | Laboratorio Chile S.A. | $894.285 |
| 5051-1-SE13 | 02-01-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $724.253 |
| 5051-5624-SE12 | 31-12-2012 | Glaxosmithkline Chile Farmaceutica Limitada | $1.056.117 |
| 5051-5623-SE12 | 31-12-2012 | Glaxosmithkline Chile Farmaceutica Limitada | $984.745 |
| 5051-5621-SE12 | 31-12-2012 | Megalabs Chile S.A. | $125.664 |
Fuente original:ficha mercadopublico.cl
